TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Index Pharmaceuticals AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
65,492
|
0
|
80 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
-58,926
|
-63,046
|
-69,492 |
| EBITDA |
-59,365
|
-65,042
|
-69,491 |
| Total assets |
183,912
|
202,533
|
248,379 |
| Current assets |
183,767
|
202,388
|
248,222 |
| Current liabilities |
179,968
|
173,456
|
148,188 |
| Equity capital |
3,944
|
29,071
|
100,158 |
| - share capital |
4,049
|
4,028
|
4,383 |
| Employees (average) |
5
|
6
|
6 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
2.1%
|
14.4%
|
40.3% |
| Turnover per employee |
13,098
|
0
|
13 |
| Profit as a percentage of turnover | -90.0% | -86865.0% | |
| Return on assets (ROA) |
-32.0%
|
-31.1%
|
-28.0% |
| Current ratio |
102.1%
|
116.7%
|
167.5% |
| Return on equity (ROE) |
-1494.1%
|
-216.9%
|
-69.4% |
| Change turnover |
65,492
|
-74
|
80 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-17%
|
0%
|
20% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.